We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.
- Authors
Chew, Kara W.; Moser, Carlee; Daar, Eric S.; Wohl, David A.; Li, Jonathan Z.; Coombs, Robert W.; Ritz, Justin; Giganti, Mark; Javan, Arzhang Cyrus; Li, Yijia; Choudhary, Manish C.; Deo, Rinki; Malvestutto, Carlos; Klekotka, Paul; Price, Karen; Nirula, Ajay; Fischer, William; Bala, Veenu; Ribeiro, Ruy M.; Perelson, Alan S.
- Abstract
These authors jointly supervised this work: Michael D. Hughes, Davey M. Smith. Correction to: I Nature Communications i https://doi.org/10.1038/s41467-022-32551-2, published online 22 August 2022 The original version of this article contained an error in the Abstract, which incorrectly omitted from the end the following: "Trial Registration: ClinicalTrials.gov Identifier: NCT04518410".
- Subjects
COVID-19; ANTIVIRAL agents; ADULTS
- Publication
Nature Communications, 2023, Vol 14, Issue 1, p1
- ISSN
2041-1723
- Publication type
Correction Notice
- DOI
10.1038/s41467-023-35835-3